Additional file 1: of The anatomical pathology of gout: a systematic literature review

Example search strategy from PubMed using Advanced Search. (DOCX 15 kb

Additional file 1: Table S1. of Factors influencing the crystallization of monosodium urate: a systematic literature review

Summary of journal articles included in the review categorized by the relevant stage of crystallization. (DOCX 37 kb

Additional file 3 of Patient participation in defining best-practice rheumatology service provision in Aotearoa New Zealand: a qualitative study with service consumers

Additional file3. Interview Schedule. The interview schedule for the focus group and interview

Additional file 1 of Patient participation in defining best-practice rheumatology service provision in Aotearoa New Zealand: a qualitative study with service consumers

Additional file1. COREQ (COnsolidated criteria for REporting Qualitative research) Checklist

Additional file 2 of Patient participation in defining best-practice rheumatology service provision in Aotearoa New Zealand: a qualitative study with service consumers

Additional file2. Table 1: GRIPP2 long form

Additional file 4 of Patient participation in defining best-practice rheumatology service provision in Aotearoa New Zealand: a qualitative study with service consumers

Additional file4. Table S1. Statements used in Delphi exercise with rheumatologists describing potential components of a best-practice rheumatology service in DHB in AoNZ [24]

Additional file 1 of Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials

Supplementary Table 1. Participant inclusion and exclusion criteria and adverse event assessment methods of included studies. Table 2. Frequency of any adverse event reported in colchicine and comparator groups. Table 3. Meta-analysis results showing pooled risk ratio of adverse events between colchicine and pooled comparator groups for studies not involving participants with liver diseases. Table 4. Number of participants in colchicine and comparator groups with adverse events related to gastrointestinal, liver and hematologic events. Table 5. Number of participants in colchicine and comparator groups with adverse events related to muscle, sensory, and infectious events. Table 6. Number of participants in colchicine and comparator groups with miscellaneous adverse events or death. Figure 1. Quality assessment results using the modified-Jadad score. Figure 2. Forest plot showing estimated relative risk of any adverse event during colchicine use compared to comparator groups across different durations of drug exposure. Figure 3. Forest plot showing estimated relative risk of any adverse event during colchicine use compared to comparator groups across different daily doses of colchicine. Figure 4. Forest plot showing estimated relative risk of diarrhoea during colchicine use compared to placebo and active comparator groups. Figure 5. Forest plot showing estimated relative risk of liver events during colchicine use compared to placebo and active comparator groups. Figure 6. Forest plot showing estimated relative risk of hematology events during colchicine use compared to placebo (no active comparator studies). Figure 7. Forest plot showing estimated relative risk of sensory events during colchicine use compared to placebo (no active comparator studies). Figure 8. Forest plot showing estimated relative risk of infectious events during colchicine use compared to placebo and active comparator groups

Additional file 1 of An evaluation of podiatry service use for people with inflammatory rheumatic diseases: a review of a rheumatology podiatry clinic in Aotearoa New Zealand

Additional file 1: Table S1. Baseline characteristics for referred patients who did not attend an appointment, in comparison with those who attended the Podiatric Rheumatology Clinic. Table S2. Service provision for patients who attended the Podiatric Rheumatology Clinic based on appointment level dataa (n = 1570 appointments)

Additional file 1: of Population-specific association between ABCG2 variants and tophaceous disease in people with gout

Full SLC2A9 and ABCG2 genotype distributions according to tophus status. (PDF 42 kb

Results of the Delphi exercise for important features of retail footwear for women with RA.

Results of the Delphi exercise for important features of retail footwear for women with RA.</p